Louisa and is the Business Partnerships Lead for the Pathogen Program at EIT. In her role, she will support the transformative goals of the Pathogen mission through active engagement and partnering with industry players, both new and established.

Prior to joining EIT, Louisa held commercial leadership positions at Oxford Nanopore Technologies, where she developed and led the global sales organisation and market development functions; at Horizon Discovery (now Revvity) as head of Diagnostic Reference Materials sales, and in sales roles at Source BioScience UK and Roche Diagnostics Australia.

Louisa holds an Executive MBA from the Saïd Business School, University of Oxford, alongside a PhD in Molecular Biology, and an honours bachelor degree in biomedical science from Monash University.